Abgenix
Name change to <b>Amgen</b>
<b>Press releases archived for reference only.</b>
Fremont
California
United States
28 articles about Abgenix
-
Strategic Diagnostics Inc. Elects Dr. C. Geoffrey Davis, Founder and Chief Scientific Officer for Abgenix, Inc., to Board of Directors
9/4/2007
-
Amgen Lays Off Fremont Workers As Part Of $2 Billion Abgenix Acquisition
4/6/2006
-
The Day In Review: ViroPharma Incorporated Climbs On Maribavir Results
3/29/2006
-
Amgen And Abgenix Complete Biologics License Application For FDA Approval Of Panitumumab
3/29/2006
-
Abgenix Announces Stockholder Approval Of Acquisition By Amgen
3/29/2006
-
Abgenix Announces 2005 Fourth Quarter And Full Year Financial Results
2/22/2006
-
Abgenix To Host Fourth Quarter And Full Year 2005 Conference Call
2/14/2006
-
Abgenix To Present At JPMorgan 24th Annual Healthcare Conference
1/5/2006
-
East Bay Biotechs Hit Sales Block
1/3/2006
-
Best Of Both Worlds
1/3/2006
-
Amgen To Acquire Abgenix For $22.50 Per Share
12/15/2005
-
Thumbs Ups Abgenix
12/1/2005
-
Abgenix Appoints Jeffrey H. Knapp As Senior Vice President Of Sales And Marketing
11/10/2005
-
Panitumumab From Amgen And Abgenix Posts Strong Data
11/3/2005
-
Amgen And Abgenix To Conduct Conference Call And Webcast Regarding Panitumumab Pivotal Study Results - November 3, 2005, 8:00 AM PT
11/3/2005
-
Abgenix And Amgen Announces Panitumumab Significantly Improves Progression-Free Survival In Phase 3 Randomized Metastatic Colorectal Cancer Study
11/3/2005
-
Abgenix Announces Third Quarter 2005 Financial Results
10/26/2005
-
The Day In Review: Biotech Tops Old High
8/1/2005
-
Abgenix Announces Second Quarter 2005 Financial Results
7/27/2005
-
The Day In Review: Small Loss For Biotech
4/27/2005